{
  "docId": "019de075-2cce-7280-b26a-b6cf6a81cc60",
  "docSlug": "0ebab7f84cc526493dad2db7df8c89e5",
  "documentTitle": "MindMed | Investor Day Presentation Deck | 61 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 61,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 21,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-2cce-7280-b26a-b6cf6a81cc60/7",
  "deckHref": "/decks/019de075-2cce-7280-b26a-b6cf6a81cc60",
  "deckJsonHref": "/decks/019de075-2cce-7280-b26a-b6cf6a81cc60.json",
  "deckAnchorHref": "/decks/019de075-2cce-7280-b26a-b6cf6a81cc60#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.04,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "Source: \"Generalized Anxiety Disorder Therapeutics Market\", Growth+ Market Reports",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b04acc7-36a1-4c45-a885-efda2ceca64e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.86,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "table",
      "text": "Drug Class, 2022, 2031 (expected), CAGR % (2022-31); Antidepressants, 1675.7, 2370.9, 3.9%; SSRI, 787.6, 1153.4, 4.3%; SNRI, 737.3, 1058.1, 4.1%; Others, 150.8, 159.3, 0.6%; Azapirones, 117.6, 137.0, 1.7%; Benzodiazepines, 823.1, 1154.2, 3.8%; Others, 323.4, 366.6, 1.4%; Total, 2939.8, 4028.7, 3.6%",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e4a94c31-3cce-4d3c-99f4-82cb0f20a971",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "US Market Revenue for GAD by Drug Class, 2022 – 2031 ($ Million)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "865906cc-18cd-4ebf-a42d-9417dafc2ebf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 7,
      "beatId": "9c7a7148-6daa-4f94-b9ac-6bd871c82cb3",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The presentation provides market analysis and size estimates for the anxiety disorder market.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}